Open AccessSevere acute respiratory syndrome coronavirus-2 antibody prevalence in people with and without HIV in rural Western Kenya, January to March 2020
Author(s) -
Trevor A Crowell,
Ibrahim I. Daud,
Jonah Maswai,
John Owuoth,
Valentine Sing’oei,
Michelle Imbach,
Nicole Dear,
Fred Sawe,
Leigh Anne Eller,
Christina S. Polyak,
Julie A Ake
Publication year - 2021
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0000000000003054
Subject(s) - asymptomatic , medicine , antibody , covid-19 , coronavirus , human immunodeficiency virus (hiv) , pediatrics , immunology , virology , disease , infectious disease (medical specialty)
Among 582 participants in Western Kenya who were retrospectively tested from January through March 2020, 19 (3.3%) had detectable SARS-CoV-2 antibodies. The prevalence of detectable SARS-CoV-2 antibodies was similar between participants with and without HIV (3.1% vs. 4%, P = 0.68). One participant reported a cough in the preceding week but others denied symptoms. These may represent cross-reactivity or asymptomatic infections that predated the first reported COVID-19 cases in Kenya.